What Does Cuvposa Do? Understanding the Anticholinergic Medication for Drooling
•
3 min read
According to clinical trial data, Cuvposa significantly reduced drooling in 75% of pediatric patients with neurological conditions, compared to only 11% on a placebo. This prescription medication, known by its active ingredient glycopyrrolate, is an oral solution used to address this often debilitating condition.
